[Setting up indicators in biobanking: why and how?].

Area of Science:

• Biomedical Research
• Biobanking
• Genetics
• Stem Cell Research
• Regenerative Medicine

Context:

• Biobanking is increasingly vital for biomedical research due to advancements in genetics, stem cells, and regenerative medicine.
• The quality and quantity of samples from biobanks directly impact research robustness and reproducibility.
• Biobanks face growing demand, increasing complexity, and significant maintenance costs within hospital settings.

Purpose:

• To establish objective criteria for evaluating biobank performance.
• To develop a framework for strategic decision-making in biobank management.
• To propose a "bioresource research impact factor" (BRIF) for biobanks.

Summary:

• The study identifies four key categories of indicators for biobank evaluation: quality, activity, scientific production, and visibility.
• A system for allocating coefficients to these indicators is proposed to quantify biobank performance.
• These indicators aim to provide objective measures for assessing the impact and efficiency of biobanking structures.

Impact:

• Provides a framework for objective biobank assessment, crucial for research integrity.
• Supports strategic planning and resource allocation for expensive biobanking infrastructures.
• Facilitates the development of a standardized "bioresource research impact factor" (BRIF) for biobanks.